Khiron Life Sciences Corp Stock (TSXV: KHRN) (OTCQB: KHRNF) - Investor Dashboard


Khiron Life Sciences
TSXV Ticker: KHRN
OTCQB Ticker: KHRNF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 35
Established: 2017
CEO: Alvaro Torres

Khiron Life Sciences – Management Team


Alvaro Torres – CEO & Director

15 years of experience in Colombian infrastructure projects and project finance, management leadership and strategy, engineering, and mergers and acquisitions. Grew SNC-Lavalin, Colombia from inception to ~2,000 person corporation. BEng, MEng, Rensselaer Polytechnic Institute & MBA, Georgetown University.

Juan Diego Alvarez – Chief Regulatory Officer

10 years of legal experience. Authority in Colombian medical cannabis regulation. Appointed by Minister of Health to create and draft regulations for legalization of medical cannabis. LLM, Columbia University, JD, Tulane University & LLB, Universidad de Los Andes. PhD law candidate.

Dr. Paulo Vega – Chief Medical Officer

25 years experience as a neurologist. Specific experience in validation studies approval process at INVIMA. MD, University of Rosario & MBA, Deusto Business School.

Matthew Murphy – Chief Compliance Officer

25 years with the U.S. DEA. Served in variety of positions, including Chief of Pharmaceutical Investigations, prior to founding the Pharma Compliance Group. Criminal Justice, Northeastern University & Masters (Education), University of Virginia.

Andrés Galofre – Chief Commercial Officer

15 years leadership experience in pharmaceutical marketing, brand management, and distribution of ethical drugs and consumer products in Latin America. Led Advil launch in Colombia that reached 28% of domestic market share from inception. MBA, La Trobe University & BBA, CESA.

Darren Collins – Chief Financial Officer

12 years of experience in finance and capital markets with investment firms and public issuers. Former CFO of global e-commerce company and one of largest cannabis market revenue producers. BComm in finance, Dalhousie University.

Carlos Orbegozo – Chief Operating Officer

18 years of pharmaceutical experience in Latin America. Kaizen process expert with a 17-year career at Merck, as Director for Mexico, Central America and the Caribbean. Expert in leading operations, sales & marketing, quality & controls, and Good Manufacturing Practices, ISO 9001, ISO 14001, and ISO 17025.

Dr. Ana María Borda – Scientific Manager

15 years of agricultural experience in Colombia. In-depth knowledge of regional growing conditions. PhD in horticultural science, University of Florida, MSc in agricultural studies, University of Queensland, BSc in biology, Los Andes University.

Significant Insider Ownership


Andres Galofre, VP of Commercial
4.12 million shares

Alvaro Torres, CEO
4.02  million shares

Mark Monaghan, Director
2.60 million shares

Sidney Himmel, Chairman of the Board
2.33million shares

Darren Collins, CFO
864K shares


Visit Khiron Life Sciences Corp.
at www.khiron.ca.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Khiron Life Sciences Corp. is a client of NCV Media, LLC. Read our full disclaimer.